These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9598184)

  • 1. Design and synthesis of the first potent, selective, and cell penetrating adenosine 5'-monophosphate deaminase inhibitors.
    Bookser BC; Kasibhatla SR; Appleman JR; Erion MD
    Adv Exp Med Biol; 1998; 431():853-7. PubMed ID: 9598184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine 5'-monophosphate deaminase inhibitors.
    Kasibhatla SR; Bookser BC; Appleman JR; Probst G; Xiao W; Fujitaki JM; Erion MD
    Adv Exp Med Biol; 1998; 431():849-52. PubMed ID: 9598183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP deaminase inhibitors. 4. Further N3-substituted coformycin aglycon analogues: N3-alkylmalonates as ribose 5'-monophosphate mimetics.
    Bookser BC; Kasibhatla SR; Erion MD
    J Med Chem; 2000 Apr; 43(8):1519-24. PubMed ID: 10780908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP deaminase inhibitors. 3. SAR of 3-(carboxyarylalkyl)coformycin aglycon analogues.
    Kasibhatla SR; Bookser BC; Probst G; Appleman JR; Erion MD
    J Med Chem; 2000 Apr; 43(8):1508-18. PubMed ID: 10780907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMP deaminase inhibitors. 2. Initial discovery of a non-nucleotide transition-state inhibitor series.
    Bookser BC; Kasibhatla SR; Appleman JR; Erion MD
    J Med Chem; 2000 Apr; 43(8):1495-507. PubMed ID: 10780906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and synthesis of inhibitors of adenosine 5'-monophosphate deaminase.
    Lindell SD; Moloney BA; Hewitt BD; Earnshaw CG; Dudfield PJ; Dancer JE
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1985-90. PubMed ID: 10450967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.
    Kasibhatla SR; Bookser BC; Xiao W; Erion MD
    J Med Chem; 2001 Feb; 44(4):613-8. PubMed ID: 11170651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rate constant describing slow-onset inhibition of yeast AMP deaminase by coformycin analogues is independent of inhibitor structure.
    Merkler DJ; Brenowitz M; Schramm VL
    Biochemistry; 1990 Sep; 29(36):8358-64. PubMed ID: 2252896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of inhibitors of adenosine and AMP deaminases.
    Bojack G; Earnshaw CG; Klein R; Lindell SD; Lowinski C; Preuss R
    Org Lett; 2001 Mar; 3(6):839-42. PubMed ID: 11263895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine-5'-phosphate deaminase. A novel herbicide target.
    Dancer JE; Hughes RG; Lindell SD
    Plant Physiol; 1997 May; 114(1):119-29. PubMed ID: 9159944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrostatic potential surfaces of the transition state for AMP deaminase and for (R)-coformycin, a transition state inhibitor.
    Kline PC; Schramm VL
    J Biol Chem; 1994 Sep; 269(35):22385-90. PubMed ID: 8071366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5'-methylthio coformycins: specific inhibitors for malarial adenosine deaminase.
    Tyler PC; Taylor EA; Fröhlich RF; Schramm VL
    J Am Chem Soc; 2007 May; 129(21):6872-9. PubMed ID: 17488013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biochemical properties of 8-amino-6-fluoro-9-beta-D-ribofuranosyl-9H-purine.
    Secrist JA; Bennett LL; Allan PW; Rose LM; Chang CH; Montgomery JA
    J Med Chem; 1986 Oct; 29(10):2069-74. PubMed ID: 3489838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important is the N-3 sugar moiety in the tight-binding interaction of coformycin with adenosine deaminase?
    Hosmane RS; Hong M
    Biochem Biophys Res Commun; 1997 Jul; 236(1):88-93. PubMed ID: 9223432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-nucleoside analogues as potential antimalarials that selectively target Plasmodium falciparum adenosine deaminase.
    Brown DM; Netting AG; Chun BK; Choi Y; Chu CK; Gero AM
    Nucleosides Nucleotides; 1999; 18(11-12):2521-32. PubMed ID: 10639753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and structure based design of inhibitors of AMP and adenosine deaminase.
    Lindell SD; Maechling S; Klein R; Freigang J; Laber B; Blanazs L; Leonhardt M; Haupt S; Petry T; Sabina RL
    Bioorg Med Chem; 2021 Aug; 43():116272. PubMed ID: 34157570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and metabolic specificity of methylthiocoformycin for malarial adenosine deaminases.
    Ho MC; Cassera MB; Madrid DC; Ting LM; Tyler PC; Kim K; Almo SC; Schramm VL
    Biochemistry; 2009 Oct; 48(40):9618-26. PubMed ID: 19728741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding thermodynamics of the transition state analogue coformycin and of the ground state analogue 1-deazaadenosine to bovine adenosine deaminase.
    Castro C; Britt BM
    J Enzyme Inhib; 2001; 16(3):217-32. PubMed ID: 11697042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray crystallographic analysis of adenosine 5'-monophosphate deaminase (AMPD) from Arabidopsis thaliana in complex with coformycin 5'-phosphate.
    Han BW; Bingman CA; Mahnke DK; Sabina RL; Phillips GN
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Aug; 61(Pt 8):740-2. PubMed ID: 16511144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylate deaminase: potent inhibition by 2'-deoxycoformycin 5'-phosphate.
    Frieden C; Gilbert HR; Miller WH; Miller RL
    Biochem Biophys Res Commun; 1979 Nov; 91(1):278-83. PubMed ID: 518627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.